Yes, tailored screening is one aspect. Prophylactic surgery is another option. There are also pharmacological measures eg tamoxifen to reduce risk of breast can

Yes, tailored screening is one aspect. Prophylactic surgery is another option. There are also pharmacological measures eg tamoxifen to reduce risk of breast cancer in BRCA1/2 carriers. Then there are clinical trials of preventative interventions eg denosumab in BRCA carriers.